The Patent 1000 focuses exclusively on patent practice and has firmly established itself as the definitive 'go-to' resource for those seeking world-class legal patent expertise.
Recommended - Individuals: prosecution
“Boult Wade Tennant is an excellent, top-tier firm which is always responsive to requests. The quality of work is of the highest standard even when working to tight deadlines or with short notice. It has also been very innovative in devising a new fee structure based on a modern, streamlined approach to work, which saves time for both sides and enables significant reduction of costs.” With feedback like this coming in from clients, it is no wonder that Boult Wade Tennant continues to be considered one of the United Kingdom’s strongest patent prosecution outfits. It is also one of the largest – with 41 partners working across six offices internationally – meaning that no matter the technological niche, there is an expert on hand to help. The group has filed 2,500 European patent applications since 2021 and over 1,900 have been granted, which makes for an impressive rate of success. One recent highlight is its defence of Abbott in multiple EPO oppositions in relation to heart valve repair devices – dealing with this piece are Nick McLeish and Daryl Penny, both of whom sit within the high-technology and electrical group. Senior partner McLeish heads the group and has been a partner since 1995, working in areas from medical devices to nuclear physics, whereas physicist Penny counts the aerospace field and computer-implemented inventions among the many strings to his bow. Also in the high-technology group are Simon Kahn and Jonathan Palmer – communication systems expert Kahn “has very strong, adaptable technical skills in drafting complex cases, is highly knowledgeable on the law and provides solid strategic thinking when it comes to prosecution”; physics PhD Palmer meanwhile is known for his work at the interface of electronics and biotechnology. Heading up the biotechnology and life sciences group is Nina White – whose recent credits include devising the patent strategy of clinical stage biopharmaceutical company iTeos alongside deft portfolio manager Edward Ronan, who is a natural fit for the project thanks to his vaccine-related doctorate. Also in the biotechnology group is Matthew Spencer, whose knowledge of cutting-edge technical subject matter is a big help to burgeoning enterprises as well as global companies like Abcam, for which Boult Wade Tennant manages a portfolio of around 300 patent cases. Running the chemical and materials group is Adrian Hayes, a contentious ace who is known for attending around 20 hearings a year before the EPO. He is joined by Rohan Setna, Daniel Weston and Oliver Rutt. Setna is a similarly regular EPO advocate and an authority on semiconductors, while Weston is the one to go to for freedom-to-operate projects, having spoken at international conferences on the topic. Solid state chemistry boffin Rutt perfectly balances attention to detail with a big-picture approach, managing patent portfolios with finesse. The engineering and designs department includes Tessa Bucks and James Short – Bucks heads the group and splits her time between dispensing strategic and commercially minded advice and acting before the EPO, while Short has a combined academic background in computer science and engineering science, which comes in handy when fighting for multinationals in oppositions. Finally, dividing his days between patent and trademark work is Tony Pluckrose, an ally to start-ups in both the electrical and mechanical engineeringfields.